Email:
Call Us:
+92-300-2394993 +92-334-3601188
Email:
Call Us:
+92-300-2394993 +92-334-3601188
Medical Information on care and cure for better life
Pharma+Plus provides detailed information on all the drugs available in Pakistan in alphabetical order along with their respective therapeutic categories for quick and easy reference. Each chapter of this book provides Pharmacological Coding that represents its corresponding therapeutic groups. These therapeutic classifications, used internationally by institutions such as European Pharmaceutical Marketing Research Association (EphMRA)[1], are taken from the Anatomical Therapeutic Chemical Classification System (ATC Guidelines 2018). The Anatomical Therapeutic Chemical (ATC) classification system and the Defined Daily Dose (DDD)[2] as a measuring unit are recommended by the WHO for drug utilization monitoring and research purposes. The system is widely used internationally.
The purpose of preparing guidelines is to make information about the ATC/DDD system available to the users. It provides classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical characteristics. It is controlled and revised by the World Health Organization Collaborating Centre for Drug Statistics Methodology (WHOCC), and was first published in 1976[3].
The Generic name of any drug is the chemical name of the drug prescribed internationally and is mentioned underneath the brand name of the drug followed by drug contents which indicates active ingredients of the drug, however, in some cases there are no generic names mentioned underneath brand names only drug contents are mentioned, the reason behind this exception is the complex nature of the drug and large number of active ingredients in the drug, such as Multivitamins, Haematinics , and some other preparations.
1. EphMRA Anatomical Classification Guidelines 2016" EphMRA. Retrieved 7 January 2017
2. WHO Guidelines for ATC classification and DDD assignment 2018
3. WHO Collaborating Centre for Drug Statistics Methodology